/PRNewswire/ -- Among the many technologies that are now being integrated with healthcare systems are wearable devices. In effect, medical device manufacturers...
/PRNewswire/ -- The wearable technology market has evolved in recent years into a major tech segment, in large part thanks to consumer market growth which is...
Nemaura Medical, Inc. (NMRD) delivered earnings and revenue surprises of 61.11% and 98.50%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?...
Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable sensors and supporting personalized...
Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable sensors and supporting personalized...
Nemaura Medical, Inc. (NMRD) delivered earnings and revenue surprises of 0% and 75.33%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing a daily disposable, wearable glucose sensor and supporting personalized lifestyle coaching programs,...
/PRNewswire/ -- In the modern technologically-driven healthcare landscape, the business model of medical device companies has evolved from device makers to...
Nemaura Medical (NASDAQ: NMRD) was featured in the Bell2Bell Podcast, a part of IBN’s (InvestorBrandNetwork) sustained effort to provide specialized content distribution via widespread syndication channels....
In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on Nemaura Medical (NMRD – Research Report), with a price target of $12.00. The company's shares closed last Friday at...